<DOC>
	<DOCNO>NCT00358748</DOCNO>
	<brief_summary>The purpose study investigate early use hydrocortisone hypotensive low birth weight infant . Based observation : - hypotension common problem low birthweight infant associate brain injury poor neurological outcome ; - infant refractory standard treatment ( volume expansion vasopressor ) , exempt adverse effect ; - relative adrenal insufficiency describe population ; hypothesize hydrocortisone effective treatment hypotension population reduce need vasopressor .</brief_summary>
	<brief_title>Early Use Hydrocortisone Hypotensive Very Low Birth Weight Infants</brief_title>
	<detailed_description>Eligible infant randomly assign receive hydrocortisone placebo , use sequentially number , preassigned treatment designation seal , opaque envelope . The study drug randomly assign patient number , advance , use computer-based random number generator . Hydrocortisone placebo dos prepare provided hospital pharmacy follow assign study number . Active placebo drug solution completely indistinguishable . Infants multiple gestation randomize separate subject . Crossover study group allow . Physicians involved care infant blind treatment group allocation . If infant remain hypotensive Normal Saline ( NS ) bolus 10 ml/kg , blood serum cortisol level determination draw hydrocortisone equivalent volume NS placebo administer intravenously follow : first dose immediately randomization 2 mg/kg ; 6 hour 1 mg/kg q6h 3 dos ; follow 0.5 mg/kg q6hs 4 dos . If infant respond initial dose NS become hypotensive within 1 hour also randomize , otherwise another NS bolus could administer . Initiation escalation inotropes : Concurrently first dose study drug , dopamine infusion start 5 mcg/kg/minute , increase stepwise maximum 15 mcg/kg/minute . If hypotension persist epinephrine infusion 0.05 mcg/kg/min add increased stepwise necessary . The aim maintain mean blood pressure ( MBP ) hypotensive limit define inclusion criterion . Weaning inotropes : Once normotension maintain 1 hour MBP &gt; 40 mmHg 15 minute , wean start . Dopamine infusion reduce first , tolerate , 5 mcg/kg/minute . If subject epinephrine infusion dose reduce stepwise 0.05 mcg/kg/minute discontinue . When subject epinephrine and/or dopamine 5 mcg/kg/minute , dopamine discontinue . If time hypotension recurs , wean hold increased inotropes dose per escalation algorithm .</detailed_description>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Gestational age ≤ 30 week , Birth weight ≤ 1250 gram ≤ 48 hour age ; Umbilical peripheral arterial catheter place ; Invasive mean blood pressure &lt; gestational age complete week 1 Normal Saline bolus 10 ml/kg ; Parental/legal guardian consent . Clear evidence hypovolemia ( blood loss ) ; Chromosomal abnormality ; Hydrops fetalis ; Major congenital anomaly ; Cardiac lesion patent ductus arteriosus .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>30 Weeks</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Preterm</keyword>
	<keyword>hypotension</keyword>
	<keyword>steroid</keyword>
	<keyword>hydrocortisone</keyword>
</DOC>